PharmaCyte Biotech Inc (PMCB) — Cash Flow-to-Debt Ratio
PharmaCyte Biotech Inc (PMCB) has a Cash Flow-to-Debt Ratio of -0.05x as of January 2026, meaning its operating cash flow of $-786.85K could theoretically repay 0% of its total liabilities ($16.47 Million) in one year. Explore investment intensity of PharmaCyte Biotech Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PharmaCyte Biotech Inc Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for PharmaCyte Biotech Inc across 24 annual periods. Also explore PMCB asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for PharmaCyte Biotech Inc (2002–2025)
Year-by-year debt coverage analysis for PharmaCyte Biotech Inc. For market capitalisation and broader financial context, see PharmaCyte Biotech Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.91x | $-2.98 Million | $3.28 Million | ▼ -761.2% |
| 2024 | -0.11x | $-2.15 Million | $20.39 Million | ▲ +98.4% |
| 2023 | -6.47x | $-3.79 Million | $586.58K | ▼ -10.6% |
| 2022 | -5.85x | $-4.12 Million | $704.37K | ▼ -27.2% |
| 2021 | -4.60x | $-3.33 Million | $724.78K | ▼ -111.8% |
| 2020 | -2.17x | $-2.34 Million | $1.08 Million | ▲ +44.0% |
| 2019 | -3.87x | $-2.88 Million | $742.85K | ▲ +50.9% |
| 2018 | -7.89x | $-5.08 Million | $644.17K | ▼ -37.0% |
| 2017 | -5.76x | $-3.34 Million | $580.25K | ▲ +15.6% |
| 2016 | -6.82x | $-4.35 Million | $637.64K | ▼ -200.8% |
| 2015 | -2.27x | $-4.56 Million | $2.01 Million | ▲ +45.8% |
| 2014 | -4.18x | $-1.56 Million | $373.67K | ▼ -3968.3% |
| 2013 | -0.10x | $-390.43K | $3.80 Million | ▼ -73.1% |
| 2012 | -0.06x | $-259.29K | $4.37 Million | ▼ -4.6% |
| 2011 | -0.06x | $-225.23K | $3.97 Million | ▲ +81.6% |
| 2010 | -0.31x | $-974.06K | $3.15 Million | ▲ +25.7% |
| 2009 | -0.42x | $-1.19 Million | $2.85 Million | ▲ +93.7% |
| 2008 | -6.60x | $-1.19 Million | $180.56K | ▼ -122.9% |
| 2007 | -2.96x | $-351.60K | $118.81K | ▼ -99.8% |
| 2006 | -1.48x | $-1.07 Million | $723.89K | ▲ +13.6% |
| 2005 | -1.71x | $-2.80 Million | $1.63 Million | ▼ -155.4% |
| 2004 | -0.67x | $-221.03K | $329.13K | ▲ +95.5% |
| 2003 | -14.84x | $-37.46K | $2.52K | ▼ -574.6% |
| 2002 | -2.20x | $-21.99K | $10.00K | — |